In Collaboration with:
Vote on your phone or ipad at the following address:
Organ transplantation remains the gold standard therapy for children with end-stage organ failure, however for neonatal patients, mortality on the transplant waiting list and following transplantation remains disproportionally and unacceptably high. Although preventable mortality may be organ-specific, there may also be common causes and thus, opportunities to develop bridging strategies to facilitate infants getting to an age or size where the outcomes following transplantation are more favorable.
In this IPTA-AST joint session, we propose to have organ-specific experts discuss the current management, challenges, and potential strategies that will lead to more successful transplantation of neonates with identified end-stage organ failure.